secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sana Biotechnology, Inc. (SANA)
CIK:        0001770121
Form:       8-K
Filed at:   2025-09-05T23:59:59+00:00
Accession:  0001193125-25-196414
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Sana Biotechnology GC Bernard Cassidy to retire Oct 20; Aaron Grossman named successor
--------------------------------------------------------------------------------

- Bernard Cassidy will retire as EVP, General Counsel, effective Oct 20, 2025.
- Aaron Grossman appointed EVP, Chief Legal Officer, starting Oct 20, 2025.
- Cassidy's retirement is voluntary for personal reasons; no disagreement with Company.
- Cassidy expected to provide transition services after retirement date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1770121/000119312525196414/0001193125-25-196414-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1770121/000119312525196414/sana-20250904.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-196414

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer